Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01562236
Other study ID # gender148
Secondary ID
Status Completed
Phase N/A
First received March 22, 2012
Last updated March 22, 2012
Start date January 2000
Est. completion date October 2011

Study information

Verified date March 2012
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Observational

Clinical Trial Summary

Background and objectives: Male sex is a risk factor for poor neurodevelopmental outcome following preterm birth. The investigators aimed to investigate gender-related differences in amplitude-integrated electroencephalography (aEEG) and to correlate these findings with neurodevelopmental outcome.

Methods: Preterm infants born <30 weeks' gestational age between 2000 and 2002 were prospectively included. aEEGs obtained within the first two weeks of life were evaluated and classified according to background activity, sleep-wake cycling (SWC) and seizure activity. Outcome was assessed at three years.


Recruitment information / eligibility

Status Completed
Enrollment 148
Est. completion date October 2011
Est. primary completion date December 2002
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 24 Weeks to 30 Weeks
Eligibility Inclusion Criteria:

- born<30 weeks gestational age

- who had aEEGs in first 2 weeks of life

- who were assessed for outcome at 3 years of age

Exclusion Criteria:

- born>30 weeks gestational age

- had no aEEGs in first 2 weeks of life

- lost for follow-up at 3 years

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Gender Role Disorder, Male to Female Type

Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria,